Overview

Building Pharmaceutical Resilience

Pharmaceutical crime presents a growing strategic risk to patient safety, supply chain integrity, regulatory compliance and public trust. FACT’s Pharmaceutical Resilience Framework helps organisations understand their exposure, identify vulnerabilities, investigate incidents and build lasting resilience. Our solutions combine threat intelligence, independent investigations, digital evidence, online monitoring, assurance and executive advice.

Whether responding to counterfeit or diverted medicines, supply chain compromise, fraud, corruption or illicit online activity, FACT’s continuous cycle of improvements provides practical, evidence-based support tailored to each organisation’s risk profile.

  • Practical framework for prevention, response and resilience
  • Intelligence & Threat Assessment
  • Incident Response & Investigations
  • Assurance & Resilience Reviews
  • Executive Advisory & Crisis Support
  • Digital Evidence & Online Threats
Lead
  • Mark Jackson

    Pharmaceuticals Advisor
Download

Download our brochures.

Brochure

FACT Pharma Resilience Framework

Intelligence-led prevention, investigation and resilience against pharmaceutical crime.

PDF · approx. 3 MB
Brochure

Pharmaceutical Crime: Risks Across the Pharmaceutical Ecosystem

Our whitepaper sets out why pharmaceutical crime should be treated as an enterprise risk, and how organised crime, cyber-enabled offending, fraud and supply chain exploitation converge across the medicines ecosystem. It is written for manufacturers, healthcare providers, wholesalers, logistics partners, regulators and law enforcement, and introduces our Pharma Resilience Framework for understanding exposure and responding with confidence.

PDF · approx. 5 MB

Need something more specific, or a sector-tailored briefing? Contact Us.

Request

Get the brochures

Complete the short form to access your download

Name(Required)
Country(Required)
By downloading you agree to our privacy notice. FACT will contact you in connection with this enquiry.